Navigation Links
4C Controls Announces the Appointment of Dr. Philip Hayden as Vice President, Security Assessment & Threat Analysis

4C Controls Inc. (OTCBB: FOUR.OB) today announced it has appointed FBI Supervising Special Agent (Ret.) Dr. Philip Hayden as its Vice President, Security Assessment & Threats Analysis.

NEW YORK (Business Wire EON) August 18, 2008 -- Dr. Hayden comes to 4C Controls after a distinguished career with the Federal Bureau of Investigation. Dr. Philip Hayden has spent years involved in many aspects of law enforcement and security. While in the United States Army, he was trained in infantry and demolitions and went through airborne, ranger, pathfinder, jungle and sniper schools. He received the Purple Heart, Bronze Star for Valor and the Distinguished Service Cross for his heroic actions in Vietnam.


  • Hayden comes to 4C Controls mandated to establish the world's finest security assessment team. With 4 decades of experience in law enforcement, military, counter-terrorism and security and surveillance, Dr. Hayden's expertise working with the management team at 4C Controls assures both capability and dedication at the heart of every 4C Controls project.


Since the early 1970s, Dr. Hayden worked as a Supervisory Special Agent for the Federal Bureau of Investigation as a case agent where he was involved in criminal cases, organized crime, and foreign counterintelligence. He also served as a program manager and tactical instructor at the FBI Academy in Quantico, Virginia. Dr. Hayden has certifications in Tactics and Defensive Tactics, Special Weapons and Tactics (SWAT), Crisis Management, Firearms and Hostage Negotiation. Through his many years of experience, training and instructing, he has designed, developed and implemented lesson plans on subjects ranging from making arrests and handling subjects to tactical air operations. Dr. Hayden has authored numerous law enforcement articles and produced a variety of videos on law enforcement techniques.

  • a private consultant, Dr. Hayden has conducted security assessments and designed security analysis programs for the public and private sectors.

  • the past decade, Dr. Hayden has used his knowledge and experience as an expert witness specializing in areas of law enforcement such as use of force, arrest procedures and tactical training. He has coordinated and directed training for police officers and designed programs for national and international police officer safety and survival courses.. He has also lectured and been a keynote and motivational speaker at national and international police conferences, colleges and universities.

  • Hayden is also an internationally known and highly regarded business consultant and thought leader focused on the creation and refinement of effective business strategies. He is an expert in the development of management teams, the execution of business plans and the development and training of the people that execute those strategies.

  • a thought leader in the concept of consultative relationship building and customer maximization strategies, Dr. Hayden has pioneered these ideas throughout the financial services industry, business services segment and the insurance/risk mitigation business platforms. His innovative approaches to strategy, training and people empowerment lead the way to better customer relationships, stronger more cohesive internal teams and improved business results.


  • Controls is an early stage company offering high technology integrated security solutions positioning to provide "real time" threat detection within a framework of "next generation" command, control and response capabilities.

With a focus on acquiring and developing broad new technologies integrating high resolution synthetic aperture satellite (SAR) imagery, proprietary ground radar systems along with access control and electronic surveillance utilizing advanced biometric solutions, radio frequency identification (RFID), real-time locating systems (RTLS) in conjunction with traditional optical and sensor technologies 4C Controls will stand ready to assume a critical solution set for this ever growing market sector.

Forward-Looking Statements

This press release contains 'forward-looking statements' as defined in the U.S. Private Securities Litigation Reform Act of 1995. These forward-looking statements are based upon currently available competitive, financial, and economic data and management's views and assumptions regarding future events. Such forward-looking statements are inherently uncertain. 4C Controls cannot provide assurances that any prospective matters described in the press release will be successfully completed or that it will realize the anticipated benefits of any transactions. Actual results may differ materially from those projected as a result of certain risks and uncertainties, including but not limited to: global economic and market conditions; the war on terrorism and the potential from war or other hostilities in other parts of the world; availability of financing and lines of credit; successful integration of acquired or merged businesses; changes in interest rates; management's ability to forecast revenues and control expenses, especially on a quarterly basis; unexpected decline in revenues without a corresponding and timely slowdown in expense growth; its ability to retain key management and employees; intense competition and the ability to meet demand at competitive prices and to continue to introduce new products and new versions of existing products that keep pace with technological developments, satisfy increasingly sophisticated customer requirements and achieve market acceptance; relationships with significant suppliers and customers; as well as other risks and uncertainties, including but not limited to those detailed from time to time in the 4C Controls SEC filings. 4C Controls undertakes no obligation to update information contained in this release.

Read the full story at

Source: PRWeb
Copyright©2008 Vocus, Inc.
All rights reserved

Related biology technology :

1. Logical Therapeutics Inc. Announces Results of Phase 1b Clinical Study of its Naproxen Prodrug
2. Lotus Pharmaceuticals Announces Second Quarter 2008 Results
3. Yongye Biotechnology International Announces Second Quarter Results
4. China Kangtai Cactus Biotech Announces Record Second Quarter Results
5. AMDL Inc. Announces Second Quarter 2008 Results; Company Posts $5.8 Million in Sales With a Revenue Increase of 140%
6. CV Therapeutics Announces Ranexa(R) Named Finalist for Prix Galien USA 2008 Award
7. Arno Therapeutics Announces Appointment of Brian Lenz, CPA as Chief Financial Officer
8. Fufeng Announces 2008 Interim Results With Strong Sign of Recovery
9. Advanced Life Sciences Announces Second Quarter 2008 Financial Results
10. Ondine Biopharma Announces Second Quarter 2008 Financial Results
11. Indevus Pharmaceuticals Announces Issuance of U.S. Patent for SANCTURA XR(TM)
Post Your Comments:
(Date:6/27/2016)... , June 27, 2016  Sequenom, Inc. (NASDAQ: ... to enabling healthier lives through the development of innovative ... of the United States denied ... that the claims of Sequenom,s U.S. Patent No. 6,258,540 ... eligibility criteria established by the Supreme Court,s Mayo Collaborative ...
(Date:6/27/2016)... 2016  Liquid Biotech USA ... a Sponsored Research Agreement with The University of ... from cancer patients.  The funding will be used ... with clinical outcomes in cancer patients undergoing a ... be employed to support the design of a ...
(Date:6/24/2016)... ... ... Researchers at the Universita Politecnica delle Marche in Ancona combed medical journal articles ... findings are the subject of a new article on the Surviving Mesothelioma website. ... blood, lung fluid or tissue of mesothelioma patients that can help point doctors to ...
(Date:6/23/2016)... , June 23, 2016 A person commits a ... crime scene to track the criminal down. An ... Food and Drug Administration (FDA) uses DNA evidence to track ... Sound far-fetched? It,s not. The FDA has increasingly ... support investigations of foodborne illnesses. Put as simply as possible, ...
Breaking Biology Technology:
(Date:6/1/2016)... NEW YORK , June 1, 2016 ... Biometric Technology in Election Administration and Criminal Identification to ... According to a recently released TechSci Research report, " ... Sector, By Region, Competition Forecast and Opportunities, 2011 - ... $ 24.8 billion by 2021, on account of growing ...
(Date:5/12/2016)... -- , a brand of Troubadour Research ... the Q1 wave of its quarterly wearables survey. A ... to a program where they would receive discounts for ... "We were surprised to see that so ... , CEO of Troubadour Research, "primarily because there are ...
(Date:4/28/2016)... 2016 First quarter 2016:   ... with the first quarter of 2015 The gross margin ... (loss: 18.8) and the operating margin was 40% (-13) ... Cash flow from operations was SEK 249.9 M (21.2) , ... unchanged, SEK 7,000-8,500 M. The operating margin for 2016 ...
Breaking Biology News(10 mins):